Ceva Animal Health UK has announced that following the success of it's TV advertising campaign for Feliway earlier this year, which boosted sales by 30%, it'll be running the Feliway campaign again, throughout July.
Featuring 'That Purple Cat', who is liked by over 2,300 people on Facebook, Ceva says the campaign will help raise awareness of the signs of behavioural issues in cats, such as vertical scratching, and highlight the benefits of using the pheromone. The advertisement will target Feliway's key audience and will be seen by over 5 million people when it appears on channels such as Dave, E4, Gold, More4 and Yesterday.
For further information or to view the TV advertising campaign, visit www.secrettohappypets.com.
Vetoquinol has released the second set of results from a survey of over 1000 dog owners which the company says has revealed some surprising findings on owner attitudes to pain and pain relieving medications.1
In particular, Vetoquinol says it thinks veterinary surgeons will be surprised by the depth of feeling expressed by pet owners about the issue, and that there are areas where there is potential for the profession to relate to the concerns of clients and adapt communication accordingly.
The key findings highlight that dog owners are likely to be shocked by a diagnosis of long term painful illness in their pet and are very likely to search for further information on the Internet about the pet's condition. Most dog owners think that NSAIDs are likely to cause side effects, with the perceived risk being much greater than the actual level of risk. The results also indicate that even low levels of risk of side effects may be unacceptable to dog owners.
Mark Leddy, Marketing Manager at Vétoquinol said that the strength of the bond between pet and owner should always be front of mind: "A diagnosis of osteoarthritis, for instance, is such a common one, often being made several times a day, so it is easy to become matter of fact about it; yet for the client that news may actually be quite traumatic and the impact hugely underestimated."
Where clients get their information from is important:
The majority of respondents (95%) felt that treatment of osteoarthritis should be started as soon as signs appear and then long term, either consistently or as needed. However, despite recognising the need for treatment, many expressed concerns about side effects when giving their dog long-term medication, with 77% considering it important or very important to choose a medication with a limited range of side effects.
Vetoquinol says the reality is that one in a thousand pets given an NSAID is likely to experience side effects, which vets may feel is not something owners should worry about unduly. The reality for pet owners is that they perceive the risk to be much greater and if informed of the actual level of risk may still experience a significant level of fear that their pet, with whom they have a special relationship, could be that one in a thousand.
Mark Leddy says that, based on these results, there is great scope for the veterinary team to discuss the level and type of risk entailed in administering medication: "Such an approach will help pet owners make more informed decisions about treatment, allay their concerns and provide them with the support they need at what is probably a very difficult time for them."
1. A survey of 1048 dog owners, carried out by petbuzz, on behalf of Vétoquinol, March 2011
Boehringer Ingelheim Vetmedica, manufacturer of the equine pergolide Prascend, has joined forces with the British Horse Society, Redwings Horse Sanctuary and World Horse Welfare to launch the 'Talk About Cushing's (TAC)' campaign.
The initiative, which will take place throughout September and October 2011, is aimed at raising awareness of Cushing's Disease and its clinical signs, perhaps the most familiar of which is hirsutism (abnormal hair growth, or delayed shedding). Horse owners can download a £15 money-off voucher from http://www.talkaboutcushings.co.uk/ throughout the TAC initiative, which can be redeemed through their veterinary practice against blood test costs.
Boehringer says Equine Cushing's Disease, also known as Pituitary Pars Intermedia Dysfunction (PPID), is the most common endocrine disorder in older horses and ponies1 ,and that some estimates suggest over 15% of horses and ponies over 15 years of age are affected2.
Unfortunately, the initial stages of Cushing's Disease are often difficult to detect, delaying the maximum benefit of early diagnosis and intervention. Blood testing is increasingly used to detect the disease and confirm diagnosis, however many horses with clinical signs, including recurrent laminitis, still go undiagnosed.
Craig Beck, vet and equine sales and marketing manager at Boehringer Ingelheim Vetmedica said: "More than 80% of horses suffering from laminitis may have an underlying endocrine disorder, such as Cushing's Disease3.
"The TAC campaign will raise awareness of Cushing's Disease amongst both veterinary professionals and owners. It should make it easier for vets to go ahead with endocrine testing in horses and ponies with recurrent laminitis, diagnosing and treating earlier in the course of the disease."
Lee Hackett, head of welfare at the BHS, added: "Cushing's Disease is relatively common in horses yet in our experience it frequently goes undiagnosed and untreated. This is why we are fully behind the 'Talk About Cushing's' campaign - anything that raises awareness and understanding of this disease has to be of benefit to equine welfare."
Redwings' head of veterinary services Nicky Jarvis said: "At Redwings we have many horses over the age of 15, all living very happy and healthy lives. 'Old age' is not in itself a disease so when a geriatric horse loses condition or appears unwell there is always an underlying cause. If a horse continually succumbs to laminitis or loses weight, Cushing's Disease could be one explanation. However, with early diagnosis, good management and the correct treatment a horse with Cushing's can live comfortably for many years."
"Early diagnosis of Cushing's Disease can be of great benefit, other conditions such as laminitis are often associated with it and it is important that clinical signs are recognised and treated appropriately. World Horse Welfare supports the 'Talk About Cushing's' campaign as it will help people to recognise the signs and take the right action to prevent horses from suffering," concludes Tony Tyler, deputy chief executive, World Horse Welfare.
Backed by an advertising and PR campaign in the equine consumer media, Boehringer Ingelheim Vetmedica has produced a marketing pack for veterinary practices to use in the run up to, and during TAC. This includes leaflets, invoice stickers, a veterinary practice toolkit featuring an owner evening presentation, editorial copy for newsletters and websites and images to support the campaign.
For further information on TAC or Prascend, the first licensed product for the treatment of Cushing's Disease, please visit http://www.talkaboutcushings.co.uk/, contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.
References
1. Donaldson et al. “Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis”. JAVMA, Vol 224, No. 7, April 1, 20042. McGowan. “Diagnostic and Management Protocols for Equine Cushings Syndrome” In Practice, November/December 20033. McGowan. “Epidemiology and Clinical Perspectives of Endocrinopathic Laminitis”, BEVA Congress 2009
Dechra Veterinary Products has launched Celox Veterinary, a product which stops arterial or venous haemorrhage within 3 minutes, described as 'revolutionary' by the company.
Celox Veterinary is available in both a granule formulation and in two sizes of gauze. The granules can be poured into a wound. Once pressure is applied, a clot forms and arterial and venous haemorrhage is stopped within three minutes, independent of the body's normal clotting processes. Celox Veterinary Gauze has the granules ready bonded onto its surface for ease of use.
Dechra says the product works by bonding with red blood cells and gelling with fluids to produce a robust clot which sticks to moist tissue to plug the bleeding site. It can be helpful in treating a wide range of veterinary cases including:
Celox Veterinary is made from chitosan, a natural polysaccharide and by-product of the shrimp industry. It generates no heat while in use and small amounts of residual material left in the body are naturally metabolised.
Dechra Product Manager Rachel Horton said: "Wound care is an area in which Dechra is known for its innovative product range. We are delighted to take this to the next level by offering this revolutionary treatment to vets and believe it will soon establish itself as an efficacious tool when they are faced with significant injuries and severe bleeding."
For further information on Celox Veterinary, please contact your Territory Manager or call Dechra direct on (01939) 211200.
An ectoparasitology working group has been set up to provide a set of practical guidelines for veterinary surgeons across Europe.
The group, which has been established to bring together best practice strategies in the light of changing ectoparasite threats met for the first time earlier this year.
Headed by Doctor Marie-Christine Cadiergues, lecturer, researcher and Professor in dermatology at the National Veterinary School of Toulouse in France, and hosted by Virbac, the group of six leading independent experts from across Europe - including Dr Ross Bond from the RVC - has been tasked with developing strategies which can be applied by vets when advising their clients.
Virbac's small animal ectoparasitology product manager Victoria Hudson explains that using evidence-based data where possible, the aim of the group is to produce a clear, practical set of guidelines: "These will cover treatment efficacy, practicability for client education and compliance, impact in terms of animal welfare, public health and potential resistance, and a decision tree covering a wide range of scenario presentations to define the optimal antiparasitic treatment options."
Dr Bond adds that despite the very common occurrence of flea and tick infestations in pets, control strategies can be challenging depending on individual circumstances of the case: "It is anticipated that these guidelines will assist busy veterinary practitioners in their selection of the optimal control strategy."
An initial report is expected in the press in a few weeks time.
Boehringer Ingelheim VetMedica has published its equine endocrine webinars online for veterinary professionals to view on demand at www.prascend.co.uk/webinars.
The webinars, which cover 'Diagnostic challenges in equine endocrine disease', presented by equine internal medicine specialist Andy Durham from the Liphook Equine Hospital, and 'A problem-based approach to equine laminitis', presented by equine internal medicine specialist Dr Catherine McGowan from the University of Liverpool, are each one hour long.
Participants will each receive CPD certificates for participation.
The Veterinary Development Council (VDC) is conducting a survey to investigate the role of paraprofessionals and technicians in veterinary practice, and is asking vets in large animal, equine, and mixed practices to complete a short survey.
The VDC says that information from the survey will help inform discussions on the regulation of technicians.
The survey will take between 5 and 10 minutes to complete and can be found on the BVA website at www.bva.co.uk/vdc. The BVA has also emailed the survey directly to practices.
The survey has been devised by the VDC working group looking at the role of the veterinary-led team, chaired by BVA Past President Professor Bill Reilly. This is one of three working groups that will report to the VDC:
Professor Reilly said: "The relationship between veterinary surgeons and technicians is vital but it varies from practice to practice.
"The working group on the role of the veterinary-led team aims to take a snapshot of how services, such as artificial insemination and foot trimming, are currently delivered, and gauge how veterinary surgeons feel about other services being delivered by non-veterinarians in the future.
"I hope veterinary surgeons in large, mixed and equine practice will take 10 minutes to complete our survey to help us map the current use of technicians in veterinary practice and help shape our future discussions."
Lanes Health, manufacturer of the mobility supplement, LitoVet, has announced the nominees for the inaugural Litovet Equine Scientific Achievement Award, part of the annual Animal Health Trust (AHT) awards.
The award which has been set up to recognise a person or group whose clinical or scientific work has made a substantial difference to the equine veterinary world will be judged by a panel of leading veterinary surgeons and scientists.
The nominees are:
Peter Clegg - MA VerMB PhD CertsES DepEVCS MRCVS. Dr Clegg is Professor of Equine Surgery and Deputy Head of the Institute of Ageing and Chronic Disease, Faculty of Health and Life Sciences, The University of Liverpool. Peter's current research focus is equine orthopaedics, in particular identifying the basic mechanisms of injury and repair in equine joints and tendons. He has supervised 13 successful PhD students and is currently supervising a further nine.
Andy Durham BSc, BVSc, DEIM, Dipl.ECEIM, MRCVS (RCVS & European Specialist in equine internal medicine). Liphook-based Andy Durham exemplifies the premise that veterinarians in practice can maintain an active interest in current research, undertake clinically relevant research projects, interact with researchers on an international stage and contribute to CPD through scientific papers, book chapters and lectures.
Tim Mair BVSc PhD DEIM DESTS DipECEIM MRCVS. Dr Mair ha been innovative in veterinary practice (e.g., an early adopter of standing magnetic resonance imaging [MRI]), has an extensive publication list recently focusing on evidence-based medicine for colic, but spanning the full breadth of common medical disorders in horses. He has made an enormous contribution to veterinary practice within both Europe and America in his role as Editor of Equine Veterinary Education.
Chris Proudman MA VetMB PhD CertEO FRCVS.Dr Proudman is Professor of Equine Studies at the University of Liverpool. His research interests are related to the aetiology and surgical management of acute intestinal disease (colic) in the horse: specifically, the diagnosis of intestinal parasites associated with colic and understanding dietary determinants of colic. Most recently this has involved using metabolomics and molecular microbiology to investigating the intestinal microbiota and its response to dietary change.
The LitoVet Equine Scientific Achievement Award can be granted to any individual or group that is currently undertaking, or has successfully implemented within the past ten years, one or more clinical or other research projects which has, or will, make a significant contribution to equine health and welfare.
The award will be presented to the recipient, or recipients, at the UK Equestrian Awards held at the Lancaster London on Thursday 3 November 2011.
Protexin Veterinary has launched Cystophan, a new product to aid in the management of Feline Idiopathic Cystitis (FIC).
Protexin says nearly 50% of cats with FIC will have a recurrent signs within one year, so it is important to offer a high quality product to manage the condition correctly.
Cystophan combines 3 key ingredients in a tasty artificial chicken flavour capsule for optimum effectiveness:
Cystophan is available in tubs of 30 and 240 capsules.
For further information please visit www.protexin.com.
Veterinary nurse Beverley Burnett has launched North East CPD, a new CPD provider in the North East of England.
Beverley said: "It's not always time- or cost-effective to have to travel far and wide for courses, sometimes overnight, leaving surgeries short-staffed, and what with increasing travel costs, I decided to provide courses further North.
"Courses for both veterinary surgeons and veterinary nurses start in October. Our lecturers are all very experienced professionals, qualified to the highest standard within their chosen speciality, giving you the opportunity to receive only interesting and up-to-date courses.
"Our aim is to help you develop your knowledge and skills, whilst enjoying a relaxed and friendly environment, at an affordable rate."
To find out more about current and future courses, and how to book, visit http://www.ne-cpd.co.uk/ or email: info@ne-cpd.co.uk
North East CPD is curently offering a 10% discount on your first booking!
In what is believed to be a first for the profession, a group of experts have joined forces to publish 'Chronic Pain in the Dog', a blog about managing pain.
The blog, which is sponsored by Vetoquinol and available exclusively to VetSurgeon.org members, offers opinions and advice from Dr Jo Murrell, BVSc PhD CertVA DipECVA MRCVS, Head of Anaesthesia at Bristol Vet School, Kate L White MA Vet MB DVA Dipl ECVAA MRCVS, European Specialist in Veterinary Anaesthesia & Analgesia, Associate Professor in Veterinary Anaesthesia and Clinical Sub Dean at Nottingham University Veterinary School and Krista Visser 't Hooft, DVM, DipACVIM (Internal Medicine), MRCVS, Specialist in Medicine.
A new blog entry is posted every few days, and each one focuses on just one aspect of pain management, to make it easy to digest in a busy day. The aim is to help build the clinician's understanding of the topic over time.
It is also hoped that the blog will build into a useful information resource, both to raise awareness of pain management and aid clinicians in making decisions about how to approach complex cases.
VetSurgeon members can subscribe to be alerted to new blog entries by email, and (at the time of writing) there is a prize of a £10 Amazon voucher for every 50th veterinary surgeon to do so.
Click here to read the blog and subscribe.
The Royal College of Veterinary Surgeons is calling for members to nominate veterinary surgeons and non-veterinary surgeons who merit the award of Honorary Associateship or Honorary Fellowship.
Honorary Associateships are awarded annually to people, not necessarily veterinary surgeons, by reason of their special eminence in, or special service to, the veterinary profession. Council has agreed that these should only be people ineligible for election as Honorary Fellows.
Honorary Fellowships can be awarded to up to three veterinary surgeons in any one year for their service to, or special eminence in, the cause of veterinary science.
Nominees for Honorary Fellowships must be members of the RCVS and have been a member, or held a registrable qualification, for at least 20 years.
All nominations need to include the particular reasons why the honour/award should be conferred, along with supporting statements from two referees, at least one of whom must not be a working colleague of the person nominated.
Nominations must be received by the President, Dr Jerry Davies, by Friday, 2 September 2011.
Members may download the nomination form, or request it from the RCVS Executive Office (0207 202 0761 or executiveoffice@rcvs.org.uk).
Eurovet Animal Health has launched Cardisure, a new look pimobendan which the company claims will help deliver more precise dosing in the treatment of cardiac disease.
Dogs have the widest range in bodyweight of any species, and it's long been a problem accommodating the wide variation in dosage requirements that this leads to. Having to give too many tablets in a day or the need to split small tablets can be very discouraging to owners and may lead to poorer rates of compliance.
Cardisure is available in 1.25 mg, 2.5 mg, 5 mg tablets and a 10 mg tablet size. Eurovet says the tablets are easily divisible and palatable, making it easier all round for pet owners to administer the right dose of medication to their pet.
Eurovet says the benefits of treating heart disease with pimobendan are well-established and that Cardisure gives clinicians a few more client-friendly options when it comes to treating heart disease, as well as being available in smart and professional blister packs for easy dispensing.
Virbac is launching a nationwide consumer campaign directing pet owners into practice with a special £1 off Indorex voucher promotion.
Indorex product manager Victoria Hudson said: "Participating practices also have the chance to win £250 worth of shopping vouchers for themselves. The practice returning the most client vouchers, plus two runners up, will each win Love2shop shopping vouchers which can be spent at thousands of high street stores, restaurants and attractions across the UK!"
Victoria added: "Indorex is such an easy product to use providing owners with 12 months protection against fleas in their home with just a single application. Even in the summer months, the product is UV stable so it can also be used in sunlit areas such as cars and conservatories."
Vouchers can be obtained from your local Virbac territory manager or downloaded at www.fleafreezones.co.uk/. Following customer redemption each £1money off voucher can be reclaimed by the practice with proof of purchase.
Dechra Veterinary Products has launched Rycarfa carprofen tablets for dogs and injection for cats and dogs into its Veterinary Essentials range.
Dechra's Veterinary Essentials range comprises a series of post patent products designed to offer practices the reassurance of proven, quality solutions to meet their everyday clinical needs.
In its flavoured tablet form, Rycarfa is presented in easy-to-dispense blister packs which, according to Dechra, offer the most cost-effective standard size range on the market* - 20 mg x 100 tabs; 50 mg x 100 tabs, 50 mg x 500 tabs, 100mg x 100 tabs. The tablets are licensed in dogs for the reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease, and as a follow up to parenteral analgesia in the management of post operative pain.
In injection form, Rycarfa is provided as a 50mg/ml solution in a 20 ml glass vial. In dogs it is indicated for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intraocular) surgery. In cats, it is indicated for the control of post-operative pain following surgery.
Roger Brown at Dechra said: "Carprofen is a well-established, non-steroidal anti-inflammatory. Through our Veterinary Essentials range, we are offering Rycarfa in a wide range of sizes to provide the maximum flexibility with cost effectiveness."
For further information on Rycarfa, please contact Dechra on 01939 211200.
*Gfk sales data 1 July 2011
The Royal College of Veterinary Surgeons is warning practices and would be veterinary nurse students to check that VN training courses are approved by the College, or they will not lead to qualification as a veterinary nurse.
The RCVS has reported one such course, run by Direct Veterinary Services of Oxford (http://www.direct-vets.com/), to Trading Standards: it advertises 'accredited training for veterinary nurses' leading to 'an honours degree in veterinary nursing' without being an RCVS-approved training provider or awarding organisation.
RCVS Head of Veterinary Nursing, Libby Earle said: "Would-be veterinary nurse students should always check that the course they are embarking upon will lead to a qualification that is recognised by the RCVS for the purposes of registration, or they may be in for a disappointment.
"Only those courses approved by the RCVS will lead to registration, and without registration (or listing), individuals should not call themselves veterinary nurses and cannot legally carry out medical procedures and minor surgery under Schedule 3 to the Veterinary Surgeons Act."
The College says candidates should also be wary of training providers who demand money upfront online.
All new veterinary nursing courses and qualifications must be approved by the RCVS and this process can take some time. The list of approved centres providing VN training courses, together with details of approved qualifications, are available at: http://awardingbody.rcvs.org.uk/,
VetSurgeon member Anthony Todd has started a petition amongst veterinary surgeons and nurses, calling for the installation and routine monitoring of CCTV in all pre-slaughter areas of licensed abattoirs in the UK.
The petition was triggered by a news report in the Daily Mail exposing shocking cruelty to pigs at an Essex slaughterhouse run by Cheale Meats. Staff were seen stubbing their cigarettes out on the pigs' faces, punching them and failing to stun the animals correctly, in undercover footage filmed by Animal Aid.
The Food Standards Agency, which is responsible for breaches of welfare at abattoirs, has refused to submit the footage to Defra for prosecution, on the basis that it was filmed illegally.
Anthony said: "Prosecution will automatically follow with legal video evidence.
"The exposure of the Cheale incident was fortuitous and may well be the tip of the iceberg which must be eliminated."
To sign the petition, please visit: http://www.ipetitions.com/petition/abbatoir-abuse/
The BVA is now reaching out to non-members with a three-month, no strings attached, free trial. The offer ends on 31 August.
Over the past few years the BVA membership package has changed significantly in response to the needs of veterinary surgeons across the UK at all stages of their careers.
Harvey Locke, BVA President, said: "The well-documented stresses that put members of our profession at risk of mental health problems are unacceptably high. With their focus on conflict resolution and individual support, however, we hope the BVA legal services will come to be seen as a safety net for BVA members should things go wrong at work.
"These kinds of employment issues can be hard to talk about so we hope by highlighting a few stories it will encourage others to seek the help they need from the BVA.
"The three-month free trial is an opportunity for the BVA to reach out to non-members and show them the impact of our complete membership package - from the legal and employment services and free and discounted CPD to our popular publications and money-saving financial services."
Bayer Animal Health has announced that following the success of its educational TV advertising campaign, which ran earlier this year and promoted the need to worm cats, a second advertising campaign will now run in September.
Bayer (makers of Profender Spot-on solution) says its first campaign, which ran in May, had the principal aim of driving pet owners to their vet to ask about spot-on worming for their cats.
As part of the same campaign, research was conducted on cat behaviour by interviewing cat owners and attaching 'cat cams' and 'cat navs' to nine cats around the country. The results were analysed by cat behaviour expert Roger Tabor and can be found on the website www.spotonwormer4cats.com/, both as a short video documentary and a 24-page report, entitled 'The Secret Lives of Cats'.
A consumer PR campaign was also run in parallel with the TV advertising, which Bayer says was very successful in attracting entrants to a competition to find the cat with the biggest personality. Winners of the Cats with Cat-titude competition have now been announced and profiled on www.spotonwormer4cats.com.
Dan White, Profender product manager, said: "Post campaign market research revealed there was a 5% increase in the awareness of spot-on cat worming.
"The second phase of TV advertising - using the same advert but without the online competition - will start on 4th September and will build on the success of the previous advertising. And over the following three weeks, it will be broadcast on ITV1, ITV2, Channels 4 and 5, and Sky One, and is expected to reach 7 million of our core target audience."
Veterinary practices can obtain a subtitled version of 'The Secret Lives of Cats' documentary to play in their waiting rooms, and a wide selection of support materials, by contacting their Bayer Territory Manager.
A new session has been added to Ceva Animal Health UK's Cardio Academy CPD website entitled "Thoracic X-rays: Abnormal Features".
In the 30 minute multimedia presentation, the cardiology specialist Nicole Van Israël discusses X-ray abnormalities within the cardiovascular and respiratory systems of cardiac patients. This includes a discussion on how to measure heart size and how to identify and interpret lung patterns.
Participants can then receive a CPD certificate by completing the quiz for this session. The Cardio Academy CPD website is free of charge and can be accessed on www.cardioacademy.cevalearn.com.
In addition, the first four sessions can still be accessed which cover the Pathophysiology of Mitral Valve Disease by Adrian Boswood, Clinical Examination of the Cardiac Dog by Gérard Le Bobinnec and Thoracic X-rays - How to Proceed and Thoracic X-rays - Normal Features by Nicole Van Israël.
For further information, please contact your local Ceva account manager.
Virbac has launched a new 12 month version of Suprelorin, the reversible medical castration implant for dogs, widening the options for clients seeking an alternative to surgical castration.
Product manager Chris Geddes MRCVS said: "The launch of Suprelorin 12 gives practices the chance to offer dog owners a more convenient castration option. The implant renewal can now be included with their dog's annual boosters or health check.
"The slow-release implant is inserted at the back of the neck in the same manner as a microchip. There is no anaesthetic, no surgery and no scarring. The current implant, which contains 4.7mg active and lasts for around 6 months after insertion, will continue to be available for those wanting a more brief solution or as a trial.
"Deslorelin is a GnRH superagonist which causes suppression of LH/FSH, and therefore testosterone production, leading to temporary infertility."
For further information on Suprelorin/12, please call and ask to speak to one of our veterinary advisors on 01359 243243, or contact your local Virbac territory manager.
VetSurgeon member Neil Forbes FRCVS, Specialist in Avian Medicine at Vets Now Referrals, has been dealing with a rather interesting case: an owl that swallowed a sock.
John Dowling, the owner of a falconry business and keeper of the 13 week old Indian eagle owl called Lydon noticed he was not eating properly, and then looked dazed and confused when taking part in the Stonehouse Horticultural Show & Summer Jolly. After the show, Lydon looked like he was trying to vomit but couldn't, so John took him to Vets Now Referrals in Swindon for a consultation.
Neil examined Lydon and found there was a hard swelling in his abdomen. Radiographs confirmed a bloated and very full stomach. The decision was taken to operate on Lydon to remove whatever was inside. Fearing a growth or tumour, Neil was rather surprised to find instead a smelly old sock in Lydon's stomach. With the sock successfully removed, Lydon was able to go home a few hours later, none the worse for his experience.
Lydon's owner, John, said: "Lydon is a hand-reared Indian eagle and is often in and around the house. The sock is a toy he has played with since he was a owlet, and never did I think he would, or could, have eaten it!
"I was obviously surprised when Neil found the sock in Lydon's stomach but more relieved than anything. I feared the worst but was delighted to find out it wasn't something more sinister."
Neil said: "Never in my 28 years of avian medicine experience have I treated an owl that swallowed a sock, it's just unheard of. Thankfully John brought Lydon into our clinic for a consultation upon suspicion something wasn't quite right and we were able to remove the sock preventing further health deterioration.
"We would always advise owners of pets to be careful when leaving items around the house, as you can never predict how mischievous pets can be."
BCF Technology has launched a new bovine reproduction clinical booklet which can now be ordered free from the company.
BCF says the booklet has been specifically designed as a reference guide for the reproductive tract of the cow, providing key clinical commentary and scanning images to show various stages of the fertility and reproductive processes.
The booklet was written by Kimberly Palgrave, BS BVM&S RCVS, BCF's in-house vet, and aims to help the user understand the value in using ultrasound for heard fertility management.
The company says the booklet provides essential information which will be useful to its Easi-Scan and Duo-Scan customers. The correct evaluation of the bovine reproductive tract is an essential aspect of both beef and dairy herd management and this 16 page booklet could help the user either to decide or reaffirm its interpretation.
Kimberly said: "This booklet really demonstrates BCFs commitment to learning and hopefully it will provide a quick reference guide to be used on the farm. It's ideal for students and those new to using ultrasound for cattle reproduction."
To order your free copy, visit the BCF website http://www.bcftechnology.com/, telephone +44 (0)1506 460023 or email info@bcftechnology.com.
A research project funded by The Horse Trust has made important discoveries about how two peptides regulate the inflammatory response in horses. This knowledge could help with the development of improved anti-inflammatory drugs, which are used to treat a wide range of conditions in horses.
The research project was led by Professor Fiona Cunningham at the Royal Veterinary College in Hertfordshire and Dr Karen Rickards at the Donkey Sanctuary in Sidmouth, assisted by Dr Andrew Brooks at the RVC, and by Dr Kirstie Pickles, now at the Royal (Dick) School of Veterinary Studies in Edinburgh.
Inflammation is associated with a wide range of equine diseases, including recurrent airway obstruction, laminitis and sweet itch. Anti-inflammatory drugs, such as glucocorticosteroids, mainly work by blocking the formation and/or actions of compounds produced in the horse's body that cause inflammatory responses. However, these drugs are not always effective and can have unwanted side effects.
This research, funded by The Horse Trust, aimed to find out more about two naturally-occurring peptides - chains of amino acids that are shorter than proteins - known as annexin-1 and CXCL8. Both have been shown to affect the inflammatory response but little research has been done on their effects in horses. In the long term, knowing more about these compounds could help in the development of new anti-inflammatory drugs with fewer side effects.
During inflammation, neutrophils (a type of white blood cell) stick to the cells lining blood vessels and migrate into inflamed tissue, where they ingest and break down harmful agents. Using techniques that mimic these events, CXCL8 was found to cause adherence and migration of horse neutrophils. However, when it was used in combination with another pro-inflammatory substance, neutrophil migration and adherence were markedly decreased. This suggests that attempts to reduce inflammation by blocking the actions of CXCL8 might not be as beneficial as had been thought.
At the start of the project, the researchers had no information about horse annexin-1, other than its gene sequence, so their first step was to develop a method to detect the peptide in white blood cells. They established that it was present and, as horse annexin-1 has not yet been synthesised, they used a synthetic peptide derived from annexin-1, Ac2-26, to look at the effects on horse neutrophils.
They found that Ac2-26 decreased neutrophil adherence and migration in response to other pro-inflammatory compounds, although at high concentrations the peptide itself caused some cell activation, thereby increasing inflammation. They also found that dexamethasone (a glucocorticosteroid) increased the levels of annexin-1 in cells, indicating that, as in humans, this class of drugs is likely to act in part through the formation of annexin-1.
These findings suggest that the use of compounds which mimic the actions of annexin-1 may have limitations as anti-inflammatory drugs. As glucocorticosteroids partly work by forming annexin-1, further research is needed in order to find out how annexin-1 will act in the horse's body and establish how its formation contributes to the beneficial effects of these drugs.
Professor Cunningham said: "This Horse Trust-funded research has resulted in some very interesting findings about how inflammatory cells are regulated in horses. The receptors that annexin-1 and CXCL8 act upon could be targets for new equine inflammatory drugs, but more research is needed first to fully understand their actions and how they produce these effects."
The team's research has been accepted for publication by the journal Veterinary Immunology & Immunopathology.
Kruuse UK has announced that it will be launching its new Android telemetric ECG system at BEVA 2011.
The original Televet 100 supports transmission of ECG data to a range of approx 100m (330ft), allowing recording and displaying of real time data only within a confined lunging or riding arena. By linking this system to a mobile network via 3G Android phone and a Windows 7 based tablet PC, the new Televet system overcomes this range limitation.
The new system requires the rider/horse to carry a 3G mobile phone which transmits data over the mobile internet, allowing the veterinary surgeon to display and record real time data on any PC/laptop with internet access or mobile internet connection. This also includes GPS information collected by the phone allowing the ECG, heart rate and velocity of the horse to be displayed in parallel.
The Android Telemetric ECG system is specifically targeted towards veterinary applications in the field of sports horses where extended range is particularly useful, such as endurance riding, three day eventing and racing.
Televet software can now also be integrated in Dicom infrastructures in practice for data capture and recording.
Sarah Stokes, Kruuse Equine Territory Manager said: "the flexibility and simplicity of the system along with immediate access to ECG data of patients will be an invaluable diagnostic tool for UK vets allowing vital support for patients and owners wherever they are."
Visitors to the Kruuse stand at BEVA 2011 will also have the chance to win an Acer ICONI W500 tablet worth £500.